Description
DECA D 300MG AQUILA PHARMACEUTICALS
Product Description
DECA D 300MG by Aquila Pharmaceuticals is a high-quality anabolic steroid designed to enhance muscle growth, strength, and endurance. It contains the active ingredient Nandrolone Decanoate, which is known for its powerful anabolic properties.
Specific Details
- Active Ingredient: Nandrolone Decanoate
- Strength: 300mg per ml
- Manufacturer: Aquila Pharmaceuticals
- Form: Injectable solution
- Packaging: 10ml vial
Features and Benefits
- Promotes muscle growth and development
- Increases strength and endurance
- Enhances protein synthesis
- Improves nitrogen retention
- Boosts red blood cell production
- Reduces joint pain and inflammation
- Accelerates post-workout recovery
Possible Side Effects
While DECA D 300MG is generally well-tolerated, it may cause some side effects, including:
- Estrogenic effects such as water retention and gynecomastia
- Androgenic effects such as acne and hair loss
- Suppression of natural testosterone production
- Cardiovascular issues
- Liver toxicity (only in high doses or prolonged use)
Usage and Dosage
For beginners, a dosage of 300-400mg per week is recommended, divided into two equal injections. Experienced athletes can increase the dosage to 600-800mg per week. The cycle duration should not exceed 12-16 weeks to minimize the risk of side effects.
Benefits for the Buyer
- High-quality product from Aquila Pharmaceuticals
- Enhanced muscle growth and strength
- Improved endurance and performance
- Reduced joint pain and inflammation
- Accelerated post-workout recovery
- Convenient and discreet online purchase
- Fast and reliable delivery
Why Choose Steroideapothekeerfahrungen?
Steroideapothekeerfahrungen is a trusted online sports pharmacy in Germany that offers a wide range of high-quality products. By choosing us, customers can benefit from:
- Authentic and genuine products
- Competitive prices
- Secure and discreet packaging
- Fast and reliable delivery
- Excellent customer service
Reviews
There are no reviews yet.